TRAF6 Antikörper (AA 194-378)
-
- Target Alle TRAF6 Antikörper anzeigen
- TRAF6 (TNF Receptor-Associated Factor 6 (TRAF6))
-
Bindungsspezifität
- AA 194-378
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TRAF6 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human TRAF6. Predicted cross-reactivity based on amino acid sequence homology: bovine (82 % ), pig (83 %), monkey (97 %).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Recombinant protein fragment containing a sequence corresponding to a region within amino acids 194 and 378 of TRAF6.
Type of Immunogen: Recombinant protein - Top Product
- Discover our top product TRAF6 Primärantikörper
-
-
- Applikationshinweise
- Approved: ICC (1:100 - 1:200), IF (1:100 - 1:200), IHC, IHC-P (10 μg/mL), WB (1:500 - 1:3000)
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.1 M Tris-glycine, pH 7, 10 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- TRAF6 (TNF Receptor-Associated Factor 6 (TRAF6))
- Andere Bezeichnung
- TRAF6 (TRAF6 Produkte)
- Hintergrund
-
Name/Gene ID: TRAF6
Synonyms: TRAF6, RING finger protein 85, MGC:3310, RNF85 - Gen-ID
- 7189
- UniProt
- Q9Y4K3
- Pathways
- NF-kappaB Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Hepatitis C, Toll-Like Receptors Cascades, Ubiquitin Proteasome Pathway
-